NEW YORK, Sept. 28, 2017 /PRNewswire/ -- The report on global Gastrointestinal Drugs market provides qualitative and quantitative analysis for the period of 2017 to 2023.
Read the full report: https://www.reportlinker.com/p05112184
The report predicts the global Gastrointestinal Drugs market to grow with a CAGR between 4.5 % and 5.0 % from 2017 to 2023. The global Gastrointestinal Drugs market was worth USD 46.5 Billion in 2016.The study on Gastrointestinal Drugs market covers the analysis of regions such as North America, Europe, Asia Pacific, and Rest of the World. Among the geographies North America dominated the world market and Asia Pacific anticipated growing at the highest CAGR over the forecast period.
The report on global Gastrointestinal Drugs market is a comprehensive study of demand, market size, forecasts, trends and factors affecting the global Gastrointestinal Drugs market. Moreover, the report is collective presentation of primary and secondary research findings. In addition, it provides deep insights on the factors that driving, restraining the global Gastrointestinal Drugs market. Porter's five forces model in the report provides insights into the competitive rivalry in the global Gastrointestinal Drugs market over the period of 2017 – 2023. Further, IGR- Growth Matrix given in the report brings an insight on the investment areas that existing or new market players can consider.
Research methodology
• Primary ResearchOur primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached through1. Key Opinion Leaders associated with Infinium Global Research2. Internal and External subject matter experts3. Professionals and participants from LinkedIn, Hoovers, Factiva and Bloggers
Our primary research respondents typically include1. Executives working with leading companies in the market under review2. Product/brand/marketing managers3. CXO level executives4. Regional/zonal/ country managers5. Vice President level executives.
• Secondary ResearchSecondary research involves extensive exploring through the secondary sources of information available in both public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources. The secondary sources of the data typically include• Company reports and publications• Government/institutional publications• Trade and associations' journals• Databases such as WTO, OECD, and Worldbank, among others.• Websites and publications by research agencies
Report Findings1) Drivers• Large amount of global population suffering from acute and chronic GI disorders.• Increasing prevalence of gastrointestinal disease across the globe.• Strong research and development activities in order to introduce new drugs2) Restraints• Unavailability of cure for GI related disorder.3) Opportunities• Technological advancements will offer massive growth opportunities• Increasing geriatric population which are highly susceptible to gastrointestinal related disorder, as they have comparably less immunity.
Segments Covered1) Global Gastrointestinal Drugs marketa. By drug catogery• Antineutralizers• Laxatives and Anti-diarrheal• Antiemetic• Anti-inflammatory
b. By Route of Administration• Oral• Parenteral• Rectal
c. By Disease Type• Gastroesophageal Reflux Disorder (GERD)• Inflammatory Bowel Disease• Others
d. By End User• Hospital Pharmacies• Retail Pharmacies• Others
2) Global Gastrointestinal Drugs market by Regiona. North Americab. Europec. Asia Pacificd. Row
Companies Profiled:• Abbott Laboratories• Allergan Plc• Bayer AG• AstraZeneca• Boehringer Ingelheim GmbH• GlaxoSmithKline Plc• Janssen Biotech Inc• Sanofi• Takeda Pharmaceutical
Reasons to buy this report1) Comprehensive analysis of global as well as regional markets of Gastrointestinal Drugs.2) Complete coverage of all the product type and applications segments to analyze the trends, developments in Gastrointestinal Drugs market, and forecast of market size up to 2023.a. Comprehensive analysis of the companies operating in Gastrointestinal Drugs market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.3) Infinium Global Research- Growth Matrix presents analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Read the full report: https://www.reportlinker.com/p05112184
About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
https://www.reportlinker.com
__________________________ Contact Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001
Advertisement
Read the full report: https://www.reportlinker.com/p05112184
The report predicts the global Gastrointestinal Drugs market to grow with a CAGR between 4.5 % and 5.0 % from 2017 to 2023. The global Gastrointestinal Drugs market was worth USD 46.5 Billion in 2016.The study on Gastrointestinal Drugs market covers the analysis of regions such as North America, Europe, Asia Pacific, and Rest of the World. Among the geographies North America dominated the world market and Asia Pacific anticipated growing at the highest CAGR over the forecast period.
Advertisement
The report on global Gastrointestinal Drugs market is a comprehensive study of demand, market size, forecasts, trends and factors affecting the global Gastrointestinal Drugs market. Moreover, the report is collective presentation of primary and secondary research findings. In addition, it provides deep insights on the factors that driving, restraining the global Gastrointestinal Drugs market. Porter's five forces model in the report provides insights into the competitive rivalry in the global Gastrointestinal Drugs market over the period of 2017 – 2023. Further, IGR- Growth Matrix given in the report brings an insight on the investment areas that existing or new market players can consider.
Research methodology
• Primary ResearchOur primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached through1. Key Opinion Leaders associated with Infinium Global Research2. Internal and External subject matter experts3. Professionals and participants from LinkedIn, Hoovers, Factiva and Bloggers
Our primary research respondents typically include1. Executives working with leading companies in the market under review2. Product/brand/marketing managers3. CXO level executives4. Regional/zonal/ country managers5. Vice President level executives.
• Secondary ResearchSecondary research involves extensive exploring through the secondary sources of information available in both public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources. The secondary sources of the data typically include• Company reports and publications• Government/institutional publications• Trade and associations' journals• Databases such as WTO, OECD, and Worldbank, among others.• Websites and publications by research agencies
Report Findings1) Drivers• Large amount of global population suffering from acute and chronic GI disorders.• Increasing prevalence of gastrointestinal disease across the globe.• Strong research and development activities in order to introduce new drugs2) Restraints• Unavailability of cure for GI related disorder.3) Opportunities• Technological advancements will offer massive growth opportunities• Increasing geriatric population which are highly susceptible to gastrointestinal related disorder, as they have comparably less immunity.
Segments Covered1) Global Gastrointestinal Drugs marketa. By drug catogery• Antineutralizers• Laxatives and Anti-diarrheal• Antiemetic• Anti-inflammatory
b. By Route of Administration• Oral• Parenteral• Rectal
c. By Disease Type• Gastroesophageal Reflux Disorder (GERD)• Inflammatory Bowel Disease• Others
d. By End User• Hospital Pharmacies• Retail Pharmacies• Others
2) Global Gastrointestinal Drugs market by Regiona. North Americab. Europec. Asia Pacificd. Row
Companies Profiled:• Abbott Laboratories• Allergan Plc• Bayer AG• AstraZeneca• Boehringer Ingelheim GmbH• GlaxoSmithKline Plc• Janssen Biotech Inc• Sanofi• Takeda Pharmaceutical
Reasons to buy this report1) Comprehensive analysis of global as well as regional markets of Gastrointestinal Drugs.2) Complete coverage of all the product type and applications segments to analyze the trends, developments in Gastrointestinal Drugs market, and forecast of market size up to 2023.a. Comprehensive analysis of the companies operating in Gastrointestinal Drugs market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.3) Infinium Global Research- Growth Matrix presents analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Read the full report: https://www.reportlinker.com/p05112184
About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
https://www.reportlinker.com
__________________________ Contact Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001
View original content:http://www.prnewswire.com/news-releases/gastrointestinal-drugs-market-global-industry-analysis-trends-market-size--forecasts-to-2023-300528037.html
SOURCE Reportlinker
